Literature DB >> 14609590

Prognostic significance of fixed perfusion abnormalities on stress technetium-99m sestamibi single-photon emission computed tomography in patients without known coronary artery disease.

Abdou Elhendy1, Arend F L Schinkel, Ron T van Domburg, Jeroen J Bax, Don Poldermans.   

Abstract

Fixed perfusion abnormalities in patients with known coronary artery disease (CAD) are associated with myocardial damage and adverse outcomes. However, the significance of these abnormalities in patients without known CAD is unclear. The aim of this study was to assess the prognostic significance of fixed versus reversible perfusion abnormalities in patients without known CAD. We studied 327 patients (58 +/- 11 years of age; 215 men) with no history of myocardial infarction or revascularization, who demonstrated myocardial perfusion abnormalities on stress (exercise or dobutamine) sestamibi tomographic imaging. Follow-up end points were all-cause mortality and hard cardiac events (cardiac death and nonfatal myocardial infarction). Myocardial perfusion abnormalities were reversible in 226 patients (69%) and fixed in 101 patients (31%). During a mean follow-up of 7 years, 72 patients (22%) died (cardiac death in 30) and 15 patients had nonfatal myocardial infarctions. The annual mortality rate was higher in patients with fixed abnormalities than in those with reversible abnormalities (4.4% vs 2.7%, p <0.01), whereas the annual hard cardiac event rate was not significantly different between the 2 groups (2.5% vs 2%). In a multivariate analysis model, the summed stress score was an independent predictor of hard cardiac events (risk ratio 1.7, 95% confidence interval 1.3 to 5.4). The presence of a fixed perfusion abnormality was independently associated with an increased risk of death after adjustment for clinical and stress test data and the summed stress score (risk ratio 2.5, 95% confidence interval 1.3 to 3.7). In patients with suspected, but no history of CAD, fixed perfusion abnormalities were associated with a higher risk of death compared with reversible perfusion abnormalities.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14609590     DOI: 10.1016/j.amjcard.2003.07.024

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Depressed heart rate response to vasodilator stress for myocardial SPECT predicts mortality in patients after myocardial infarction.

Authors:  Young Hwan Kim; Kyung-Han Lee; Hong Joo Chang; Eun Jeong Lee; Hyun Woo Chung; Joon Young Choi; Yong Choi; Yearn Seong Choe; Sang Hoon Lee; Byung-Tae Kim
Journal:  Int J Cardiovasc Imaging       Date:  2006-04-21       Impact factor: 2.357

2.  Relationship of technetium-99m tetrofosmin-gated rest single-photon emission computed tomography myocardial perfusion imaging to death and hospitalization in heart failure patients: results from the nuclear ancillary study of the HF-ACTION trial.

Authors:  Allen E Atchley; Ami E Iskandrian; Dan Bensimhon; Stephen J Ellis; Dalane W Kitzman; Linda K Shaw; Robert A Pagnanelli; David J Whellan; Julius M Gardin; Andrew Kao; Khaled Abdul-Nour; Greg Ewald; Mary Norine Walsh; William E Kraus; Christopher M O'Connor; Salvador Borges-Neto
Journal:  Am Heart J       Date:  2011-04-06       Impact factor: 4.749

Review 3.  Role of multimodality imaging in ischemic and non-ischemic cardiomyopathy.

Authors:  Karthikeyan Ananthasubramaniam; Ritesh Dhar; João L Cavalcante
Journal:  Heart Fail Rev       Date:  2011-07       Impact factor: 4.214

4.  Exercise testing and myocardial perfusion scintigraphy in primary care patients with chest pain of new onset.

Authors:  Morten Scheike; Staffan Nilsson; Eva Nylander
Journal:  Scand J Prim Health Care       Date:  2007-06       Impact factor: 2.581

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.